In CRC, ALDOA acts as a critical regulator of fructose metabolism, facilitating tumor progression through enhanced glycolysis and cellular proliferation, with its high expression linked to therapy resistance and poor prognosis 217. The gene discussed is ALDOA; the disease is neoplasm.